Compare Essity's latest earnings squeeze against peers and hunt for companies with sturdier profitability profiles using our curated list of 218 resilient stocks with low risk scores.
To own Essity, you need to believe in a steady hygiene and health franchise that can protect profitability even when earnings get squeezed. The latest quarter delivered higher sales but lower net income and EPS, which keeps the spotlight on cost control, pricing discipline and mix shift toward higher margin categories rather than pure growth.
The key short term swing factor is whether Essity can convert its SG&A and COGS efficiency programs into firmer margins while input costs and promotional pressure remain live issues. The biggest risk still sits in structurally weaker volumes and raw material sensitivity. This report reinforces those concerns rather than changing the story.
Among Essity’s recent disclosures, the clearest reference point for this earnings release is management’s broader plan for group wide SG&A restructuring and annual COGS productivity gains. The quarter’s lower profit on a slightly stronger top line makes that cost agenda feel very concrete. Execution on those programs is not abstract; it now underpins the equity story.
If the targeted SG&A savings and SEK 0.5 to 1.0b in yearly COGS productivity land close to plan, that could support margins even if pricing power is constrained or volumes stay muted in categories like Health & Medical or Baby. If they slip, the combination of softer earnings, inflation sensitive inputs and higher brand spending would keep pressure on returns.
Essity's narrative projects SEK 150.8b revenue and SEK 14.4b earnings by 2029. That path assumes 3.1% yearly revenue growth and an earnings increase of SEK 2.3b from SEK 12.1b today.
Uncover why Essity's fair value indicates a 4% potential downside to its current price, which leaves little room for error.
One alternate view points to Essity’s capex and portfolio shift as a possible upside catalyst, not just a cost story. The most optimistic analysts were pencilling in SEK 162.6b of revenue and SEK 16.2b of earnings by 2029. After this earnings miss, those upbeat forecasts may be revisited, so compare both sides before deciding what you believe.
Explore 3 other Essity fair value estimates, including one that suggests the potential for as much as 68% upside from the current price.
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so trust your own analysis and judgment.
If Essity has sharpened your focus on quality, use the Simply Wall St Screener to line up a broader watchlist that fits your risk, income and value preferences.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com